1.
Chen L, Zhou N, Zhang L. Efficacy and Safety of Canagliflozin in STEMI Patients with Type 2 Diabetes after PCI: A Retrospective Study. HSF [Internet]. 2024Aug.15 [cited 2024Nov.23];27(8):E898-E906. Available from: https://journal.hsforum.com/index.php/HSF/article/view/7627